Coya Therapeutics (COYA) Non-Current Assets (2021 - 2026)
Coya Therapeutics (COYA) posted Non-Current Assets of $250,341 for Q2 2026, up 905.1% from $24,908 a year earlier.
Powered by 
Analysis
Coya Therapeutics (COYA) Non-Current Assets (2021 - 2026) Analysis & Trends
At the end of FY2025, Coya Therapeutics' Non-Current Assets came in at $11,227, down 70.9% from FY2024.
- Annual Non-Current Assets has declined for three consecutive years, with a four-year compound annual growth rate of -51.8% (FY2021 to FY2025).
- In prior years, Coya Therapeutics' Non-Current Assets was $38,588 in FY2024 (-41.5%), $65,949 in FY2023 (-94.6%), $1.21 million in FY2022 (+482.4%) and $207,852 in FY2021.
- The Q2 2026 figure stands as the highest quarterly Non-Current Assets since Q4 2022.
- On a year-over-year basis, Non-Current Assets increased in 1 of the last eight quarters, with growth averaging 65.3%.
- The strongest year-over-year quarter for Non-Current Assets in the past five years was Q2 2026, with growth of 905.1%; the weakest was Q4 2023, with a decline of 94.6%.
- According to Business Quant data, Non-Current Assets for the three prior quarters was $8,420 (Q1 2026), $11,227 (Q4 2025) and $18,068 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 82.81 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 141.07 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 110.20 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 75.00 Mn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 88.47 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 61.69 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 34.86 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 159.99 Bn |
| 10 | Coya Therapeutics | 74.13 Mn | -102.42 Mn | - | 247,534.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 247,534.00 |
| Jun 30, 2026 | 250,341.00 |
| Mar 31, 2026 | 8,420.00 |
| Dec 31, 2025 | 11,227.00 |
| Sep 30, 2025 | 18,068.00 |
| Jun 30, 2025 | 24,908.00 |
| Mar 31, 2025 | 31,748.00 |
| Dec 31, 2024 | 38,588.00 |
| Sep 30, 2024 | 45,429.00 |
| Jun 30, 2024 | 52,269.00 |
| Mar 31, 2024 | 59,109.00 |
| Dec 31, 2023 | 65,949.00 |
| Sep 30, 2023 | 72,790.00 |
| Jun 30, 2023 | 79,630.00 |
| Mar 31, 2023 | 86,470.00 |
| Dec 31, 2022 | 1.21 Mn |
| Dec 31, 2021 | 207,852.00 |
API Access
Coya Therapeutics Non-Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-assets&ticker=COYA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-assets", "ticker": "COYA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-assets&ticker=COYA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();